These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34979067)

  • 61. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
    Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
    [No Abstract]   [Full Text] [Related]  

  • 62. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
    Cudkowicz ME; Titus S; Kearney M; Yu H; Sherman A; Schoenfeld D; Hayden D; Shui A; Brooks B; Conwit R; Felsenstein D; Greenblatt DJ; Keroack M; Kissel JT; Miller R; Rosenfeld J; Rothstein JD; Simpson E; Tolkoff-Rubin N; Zinman L; Shefner JM;
    Lancet Neurol; 2014 Nov; 13(11):1083-1091. PubMed ID: 25297012
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thoracic Excursion Is a Biomarker for Evaluating Respiratory Function in Amyotrophic Lateral Sclerosis.
    Iguchi N; Mano T; Iwasa N; Ozaki M; Yamada N; Kikutsuji N; Kido A; Sugie K
    Front Neurol; 2022; 13():853469. PubMed ID: 35401409
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial.
    Al-Chalabi A; Shaw P; Leigh PN; van den Berg L; Hardiman O; Ludolph A; Aho VV; Sarapohja T; Kuoppamäki M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1165-1170. PubMed ID: 31315908
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multipoint incremental motor unit number estimation versus amyotrophic lateral sclerosis functional rating scale and the medical research council sum score as an outcome measure in amyotrophic lateral sclerosis.
    Jagtap SA; Kuruvilla A; Govind P; Nair MD; Sarada C; Varma RP
    Ann Indian Acad Neurol; 2014 Jul; 17(3):336-9. PubMed ID: 25221407
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
    Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
    J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.
    de Bie E; Oskarsson B; Joyce NC; Nicorici A; Kurillo G; Han JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):17-23. PubMed ID: 27813421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis.
    Ackrivo J; Hansen-Flaschen J; Wileyto EP; Schwab RJ; Elman L; Kawut SM
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30728207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. β-PIX is critical for transplanted mesenchymal stromal cell migration.
    Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
    Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.
    Jackson C; De Carvalho M; Genge A; Heiman-Patterson T; Shefner JM; Wei J; Wolff AA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):506-512. PubMed ID: 30379086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis.
    Takahashi F; Takei K; Tsuda K; Palumbo J
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):32-39. PubMed ID: 28872914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial.
    Yao D; Ye S; He Z; Huang Y; Deng J; Wen Z; Chen X; Li H; Han Q; Deng H; Zhao RC; Lu C
    Ann Transl Med; 2021 Nov; 9(22):1653. PubMed ID: 34988162
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tamoxifen for amyotrophic lateral sclerosis: A randomized double-blind clinical trial.
    Chen PC; Hsieh YC; Huang CC; Hu CJ
    Medicine (Baltimore); 2020 May; 99(22):e20423. PubMed ID: 32481440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
    Prell T; Ringer TM; Wullenkord K; Garrison P; Gunkel A; Stubendorff B; Witte OW; Grosskreutz J
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1022-6. PubMed ID: 27010615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.
    Cudkowicz ME; Shefner JM; Schoenfeld DA; Brown RH; Johnson H; Qureshi M; Jacobs M; Rothstein JD; Appel SH; Pascuzzi RM; Heiman-Patterson TD; Donofrio PD; David WS; Russell JA; Tandan R; Pioro EP; Felice KJ; Rosenfeld J; Mandler RN; Sachs GM; Bradley WG; Raynor EM; Baquis GD; Belsh JM; Novella S; Goldstein J; Hulihan J;
    Neurology; 2003 Aug; 61(4):456-64. PubMed ID: 12939417
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS.
    Pinto S; de Carvalho M
    Front Neurol; 2019; 10():109. PubMed ID: 30873101
    [No Abstract]   [Full Text] [Related]  

  • 80. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.